In a phase 3 trial, the most recent progression-free survival analysis showed a 29% risk reduction with margetuximab compared to Herceptin in metastatic HER2+ breast cancer patients (p=0.0006). (University of California, San Francisco). Share Facebook …
See Original Article

(CNN) Popeyes declared world domination this year when it debuted the chicken sandwich that’s inspired countless think pieces, internet debates and nationwide sellouts. Now, the Louisiana chain can add “ugly Christmas sweater” to the list. That’s right.
See Original Article

The Mario Draghi era is over. Thursday will feature the first European Central Bank decision with Christine Lagarde as president. No fireworks are expected as Christine Lagarde on Thursday runs her first European Central Bank meeting since taking over as …
See Original Article

Cryptocurrencies and blockchain technology are increasingly part of millennial lives—and this demographic could determine the outcome of this week’s UK General Election. But it appears the country’s leading political parties—the Conservatives, Labour and …
See Original Article

U.S. stocks closed lower on Tuesday amid investors’ concern over a partial trade deal as the dateline for fresh U.S. tariff on China will end by this week end. Moreover, market participants are waiting for the Fed Chair’s FOMC statement to be delivered on …
See Original Article